Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In a 72-week clinical study, adults using tirzepatide alongside lifestyle modifications lost an average of 20% of their body weight
The weight loss drug semaglutide will be made available for prescription from 4 September 2023, in what its manufacturer, Novo Nordisk, has described as a controlled and limited launch of the drug
Nevertheless, there was some heterogeneity in this observation in the studies with higher baseline age, SBP, use of antihypertensive medications and duration of diabetes (SURPASS-4 and SURPASS-5) where weight loss explained roughly half of the total effect on SBP
Diabetes Care 44(6):14331442
Diamond analyzed UCSs Understanding America Study, an online panel of more than 10,000 US adults, to determine the employment and relationship status of women who started using GLP-1 weight-loss drugs, compared with women who were interested in taking GLP-1s but hadnt yet started
For more guidance on discovering and treating the cause of your chronic bloating, as well as improving your digestive health, reach out to our clinic today
